doxorubicin hydrochloride and marchantin c

doxorubicin hydrochloride has been researched along with marchantin c in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, HH; Kong, F; Lou, HX; Sun, B; Xi, GM; Yuan, HQ1
Hu, QW; Li, L; Lou, HX; Niu, HM; Sun, B; Xie, F; Yuan, HQ; Zheng, HB1
Hu, QW; Li, L; Lou, HX; Niu, HM; Sun, B; Tang, H; Yuan, HQ; Zheng, HB1

Other Studies

3 other study(ies) available for doxorubicin hydrochloride and marchantin c

ArticleYear
Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity.
    Bioorganic & medicinal chemistry, 2010, Sep-15, Volume: 18, Issue:18

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bibenzyls; Catechols; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Ethers, Cyclic; Humans; Phenyl Ethers; Rhodamine 123; Stilbenes; Vincristine

2010
Design, synthesis and biological evaluation of novel macrocyclic bisbibenzyl analogues as tubulin polymerization inhibitors.
    European journal of medicinal chemistry, 2016, Oct-04, Volume: 121

    Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; Humans; Macrocyclic Compounds; Molecular Docking Simulation; Protein Multimerization; Protein Structure, Quaternary; Structure-Activity Relationship; Tubulin Modulators

2016
Design, synthesis, biological evaluation and molecular modeling study of novel macrocyclic bisbibenzyl analogues as antitubulin agents.
    European journal of medicinal chemistry, 2017, Mar-31, Volume: 129

    Topics: Antineoplastic Agents; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Macrocyclic Compounds; Models, Molecular; Molecular Docking Simulation; Structure-Activity Relationship; Tubulin; Tubulin Modulators

2017